Publications by authors named "Ralph Quimbo"

Claim this Profile
E
Effect of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Use, and Diabetes Medication Costs Among Individuals with Type 2 Diabetes Mellitus.
Amit D Raval, Matthew H Nguyen, Siting Zhou, Michael Grabner, John Barron, Ralph Quimbo

J Manag Care Spec Pharm· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Plan Enrollment and Disenrollment of Individuals With and Without Established Chronic Disease in a U.S. Commercially Insured and Medicare Advantage Population.
Haechung Chung, Gaurav Deshpande, Julia Zolotarjova, Ralph A Quimbo, David M Kern

J Manag Care Spec Pharm· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population.
David M Kern, Lawrence Chang, Kalyani Sonawane, Cynthia J Larmore, Natalie N Boytsov, Ralph A Quimbo

Rheumatol Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns among patients with psoriasis using a large national payer database in the United States: a retrospective study.
Mwangi J Murage, David M Kern, Lawrence Chang, Kalyani Sonawane, William N Malatestinic, Ralph A Quimbo

J Med Econ· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease.
Thomas P Power, Xuehua Ke, Zhenxiang Zhao, Nicole Gidaya Bonine, Mark J Cziraky, Ralph Quimbo

Vasc Health Risk Manag· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Care and the Role of Insulin as a Vehicle to Optimizing Treatments in Diabetes Care.
Nella Bieszk, Michael Grabner, Wenhui Wei, John Barron, Ralph Quimbo

J Manag Care Spec Pharm· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data.
David M Kern, John J Barron, Bingcao Wu, Alex Ganetsky, Vincent J Willey, Ralph A Quimbo

Pragmat Obs Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of Achieving Targets of Low-Density Lipoprotein Particle Number Versus Low-Density Lipoprotein Cholesterol Level.
Michael Grabner, Deborah A Winegar, Rajeshwari S Punekar, Ralph A Quimbo, Mark J Cziraky

Am J Cardiol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting.
Swetha Rao Palli, Michael Grabner, Ralph A Quimbo, Hope S Rugo

Cancer Manag Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets.
Peter P Toth, Michael Grabner, Rajeshwari S Punekar, Ralph A Quimbo, Mark J Cziraky

Atherosclerosis· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The INITIATOR study: pilot data on real-world clinical and economic outcomes in US patients with type 2 diabetes initiating injectable therapy.
Sarah Thayer, Wenhui Wei, Erin Buysman, Lee Brekke, William Crown, Ralph Quimbo

Adv Ther· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using observational data to inform the design of a prospective effectiveness study for a novel insulin delivery device.
Michael Grabner, Yong Chen, Matthew Nguyen, Scott D Abbott, Ralph Quimbo

Clinicoecon Outcomes Res· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial.
Michael Grabner, James Chu, Swetha Raparla, Ralph Quimbo, Steve Zhou

Postgrad Med· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
Peter P Toth, Robert J Simko, Swetha Rao Palli, Dawn Koselleck, Ralph A Quimbo

Cardiovasc Diabetol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoglycemia in patients with type 2 diabetes using concomitant exenatide BID and long-acting insulin therapy.
Manjiri D Pawaskar, Amy L Blickensderfer, Byron J Hoogwerf, Ralph Quimbo, Rolin Wade

J Med Econ· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knee-attributable medical costs and risk of re-surgery among patients utilizing non-surgical treatment options for knee arthrofibrosis in a managed care population.
Judith J Stephenson, Ralph A Quimbo, Tao Gu

Curr Med Res Opin· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subacute lack of asthma control as a predictor of subsequent acute asthma exacerbation in a managed care population.
Judith J Stephenson, Ralph A Quimbo, Benjamin Gutierrez

Am J Manag Care· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence.
Sanjeev Balu, Robert J Simko, Ralph M Quimbo, Mark J Cziraky

Curr Med Res Opin· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attainment of combined optimal lipid values and the impact of lipid medication on cardiovascular outcomes and costs in a commercially insured population in the US.
Ralph A Quimbo, Robert J Simko, Mark J Cziraky, Russel T Burge

J Med Econ· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargine.
Rosalind Fabunmi, Loretta L Nielsen, Ralph Quimbo, Brock Schroeder, Derek Misurski

Curr Med Res Opin· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resource utilization impact of topiramate for migraine prevention in the managed-care setting.
Debra A Wertz, Ralph M Quimbo, Avin Z Yaldo, Marcia F T Rupnow

Curr Med Res Opin· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence with migraine prophylactic treatment and acute migraine medication utilization in the managed care setting.
Avin Z Yaldo, Debra A Wertz, Marcia F T Rupnow, Ralph M Quimbo

Clin Ther· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving optimal lipid values in patients with dyslipidemia is associated with reduced risk of cardiovascular events.
Scott L Charland, Mark J Cziraky, Ralph Quimbo, Richard H Karas, William Insull

J Clin Lipidol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the economic burden of breast cancer in a US managed care population.
John J Barron, Ralph Quimbo, Prashant T Nikam, Mayur M Amonkar

Breast Cancer Res Treat· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of costs associated with the use of etanercept, infliximab, and adalimumab for the treatment of rheumatoid arthritis.
Michael F Bullano, Brian J McNeeley, Yanni F Yu, Ralph Quimbo, Lauren P Burawski

Manag Care Interface· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis